Exposure category | Meta-OR (95% CI) | Number of studies | Test for heterogeneity p value | Selected method |
---|---|---|---|---|
*Includes the cohort studies that do not provide risk estimates by duration of consumption. | ||||
Both sexes | ||||
Mid-term | 1.1 (1.0 to 1.2) | 5 | 0.84 | Fixed effects |
Long term | 1.4 (1.2 to 1.7) | 5 | 0.55 | Fixed effects |
Ever exposed | 1.2 (1.1 to 1.4) | 6* | 0.61 | Fixed effects |
Men | ||||
Mid-term | 1.3 (1.0 to 1.7) | 4 | 0.08 | Random effects |
Long term | 1.6 (1.2 to 2.2) | 4 | 0.11 | Random effects |
Ever exposed | 1.4 (1.1 to 1.9) | 5* | 0.01 | Random effects |
Women | ||||
Mid-term | 1.0 (0.7 to 1.6) | 3 | 0.09 | Random effects |
Long term | 1.4 (0.6 to 3.6) | 3 | 0.01 | Random effects |
Ever exposed | 1.2 (0.7 to 1.8) | 5* | 0.01 | Random effects |